146 related articles for article (PubMed ID: 11522321)
1. Potentiation of NMDA receptor function through somatostatin release: a possible mechanism for the cognition-enhancing activity of GABA(B) receptor antagonists.
Pittaluga A; Feligioni M; Ghersi C; Gemignani A; Raiteri M
Neuropharmacology; 2001 Sep; 41(3):301-10. PubMed ID: 11522321
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin potentiates NMDA receptor function via activation of InsP(3) receptors and PKC leading to removal of the Mg(2+) block without depolarization.
Pittaluga A; Bonfanti A; Raiteri M
Br J Pharmacol; 2000 Jun; 130(3):557-66. PubMed ID: 10821783
[TBL] [Abstract][Full Text] [Related]
3. Selective block of rat and human neocortex GABA(B) receptors regulating somatostatin release by a GABA(B) antagonist endowed with cognition enhancing activity.
Bonanno G; Carità F; Cavazzani P; Munari C; Raiteri M
Neuropharmacology; 1999 Nov; 38(11):1789-95. PubMed ID: 10587094
[TBL] [Abstract][Full Text] [Related]
4. GABA(B) receptor antagonist CGP-36742 enhances somatostatin release in the rat hippocampus in vivo and in vitro.
Nyitrai G; Kékesi KA; Emri Z; Szárics E; Juhász G; Kardos J
Eur J Pharmacol; 2003 Oct; 478(2-3):111-9. PubMed ID: 14575795
[TBL] [Abstract][Full Text] [Related]
5. The "kynurenate test", a biochemical assay for putative cognition enhancers.
Pittaluga A; Vaccari D; Raiteri M
J Pharmacol Exp Ther; 1997 Oct; 283(1):82-90. PubMed ID: 9336311
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes.
Gemignani A; Paudice P; Bonanno G; Raiteri M
Mol Pharmacol; 1994 Sep; 46(3):558-62. PubMed ID: 7935338
[TBL] [Abstract][Full Text] [Related]
7. Human brain somatostatin release from isolated cortical nerve endings and its modulation through GABAB receptors.
Bonanno G; Gemignani A; Schmid G; Severi P; Cavazzani P; Raiteri M
Br J Pharmacol; 1996 Jul; 118(6):1441-6. PubMed ID: 8832070
[TBL] [Abstract][Full Text] [Related]
8. Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices.
Pittaluga A; Bonfanti A; Arvigo D; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):272-9. PubMed ID: 10344525
[TBL] [Abstract][Full Text] [Related]
9. Regulation of EPSPs by the synaptic activation of GABAB autoreceptors in rat hippocampus.
Davies CH; Collingridge GL
J Physiol; 1996 Oct; 496 ( Pt 2)(Pt 2):451-70. PubMed ID: 8910229
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin-induced activation and up-regulation of N-methyl-D-aspartate receptor function: mediation through calmodulin-dependent protein kinase II, phospholipase C, protein kinase C, and tyrosine kinase in hippocampal noradrenergic nerve endings.
Pittaluga A; Feligioni M; Longordo F; Arvigo M; Raiteri M
J Pharmacol Exp Ther; 2005 Apr; 313(1):242-9. PubMed ID: 15608072
[TBL] [Abstract][Full Text] [Related]
11. GABA(B) and NMDA receptors contribute to spindle-like oscillations in rat thalamus in vitro.
Jacobsen RB; Ulrich D; Huguenard JR
J Neurophysiol; 2001 Sep; 86(3):1365-75. PubMed ID: 11535683
[TBL] [Abstract][Full Text] [Related]
12. The HIV-1 coat protein gp120 and some of its fragments potently activate native cerebral NMDA receptors mediating neuropeptide release.
Gemignani A; Paudice P; Pittaluga A; Raiteri M
Eur J Neurosci; 2000 Aug; 12(8):2839-46. PubMed ID: 10971626
[TBL] [Abstract][Full Text] [Related]
13. Functional effects of somatostatin receptor 1 activation on synaptic transmission in the mouse hippocampus.
Cammalleri M; Martini D; Timperio AM; Bagnoli P
J Neurochem; 2009 Dec; 111(6):1466-77. PubMed ID: 19811607
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin-induced regulation of SST(2A) receptor expression and cellsurface availability in central neurons: role of receptor internalization.
Boudin H; Sarret P; Mazella J; Schonbrunn A; Beaudet A
J Neurosci; 2000 Aug; 20(16):5932-9. PubMed ID: 10934240
[TBL] [Abstract][Full Text] [Related]
15. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function.
Pittaluga A; Bonfanti A; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):29-38. PubMed ID: 9228187
[TBL] [Abstract][Full Text] [Related]
16. Evidence for functional native NMDA receptors activated by glycine or D-serine alone in the absence of glutamatergic coagonist.
Paudice P; Gemignani A; Raiteri M
Eur J Neurosci; 1998 Sep; 10(9):2934-44. PubMed ID: 9758163
[TBL] [Abstract][Full Text] [Related]
17. Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors.
Pittaluga A; Pattarini R; Raiteri M
Eur J Pharmacol; 1995 Jan; 272(2-3):203-9. PubMed ID: 7713164
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the glutamate receptors mediating release of somatostatin from cultured hippocampal neurons.
Fontana G; De Bernardi R; Ferro F; Gemignani A; Raiteri M
J Neurochem; 1996 Jan; 66(1):161-8. PubMed ID: 8522949
[TBL] [Abstract][Full Text] [Related]
19. External pH changes affect NMDA-evoked and spontaneous release of cholecystokinin, somatostatin and noradrenaline from rat cerebrocortical nerve endings.
Gemignani A; Paudice P; Longordo F; Raiteri M
Neurochem Int; 2004 Oct; 45(5):677-85. PubMed ID: 15234110
[TBL] [Abstract][Full Text] [Related]
20. N-methyl-D-aspartate receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid, the HIV-1 envelope protein gp120, external pH and protein kinase C inhibition.
Pittaluga A; Pattarini R; Feligioni M; Raiteri M
J Neurochem; 2001 Jan; 76(1):139-48. PubMed ID: 11145986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
